British Journal of Haematology · 1998 · 10 citations · 24 references
Life SciencesGeneticsMolecular GeneticsGene ExpressionMedical GeneticsPharmacogeneticsGenetic DisordersVon Willebrand DiseaseReactivityTransient ExpressionTransient Expression SystemsType 2 Von Willebrand DiseaseVon Willebrand Factor DisordersVon Willebrand Factor FunctionVon Willebrand Factor Multimer AnalysisVon Willebrand Factor-platelet Interaction
We report the identification in five patients (three families) affected with type 2B von Willebrand disease (VWD) of three heterozygous nucleotide substitutions at the codon for arginine 543, 545 and 578 of the mature von Willebrand factor (VWF) subunit resulting in a glutamine, proline and leucine substitution, respectively. These mutations are located in the A1 loop where prevalent type 2B mutations (Arg543Trp, Arg545Cys and Arg578Gln) have been already identified at the same positions. By in vitro mutagenesis of full-length cDNA of VWF and transient expression in Cos-7 cells, we have shown that the six corresponding mutated recombinant VWFs (Gln543, Trp543, Cys545, Pro545, Leu578 and Gln578 rVWF) exhibited quantitatively normal expression and normal multimeric pattern but increased ristocetin- and botrocetin-induced binding to platelets as compared with that for wild-type rVWF. The two mutations at position 545 induced the greatest reactivity for GPIb of corresponding rVWFs as compared to the two mutations at positions 543 and 578.
24
A Revised Classification of von Willebrand Disease
J. Evan Sadler · Thrombosis and Haemostasis · 1994 · 591 citations
Medicine, Genetics, Hematology +17
Variant von Willebrand's Disease
Zaverio M. Ruggeri, T S Zimmerman · Journal of Clinical Investigation · 1980 · 509 citations · Full text
Medicine, Hematology, Pathology +17
Biosynthesis of von Willebrand protein by human megakaryocytes.
Lee Ann Sporn, Stephen I. Chavin, Victor J. Marder et al. · Journal of Clinical Investigation · 1985 · 277 citations · Full text